Breast Cancer Treatment | Women's Health

In this episode, we will discuss breast cancer treatment with Dr. Melinda Telli, Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine. We will delve into the natural history of and treatment options for DCIS (a non-invasive form of breast cancer), including the ongoing debate in the medical community regarding treatment vs. observation for low grade DCIS. We will cover staging of invasive breast cancer, and delve into treatment options including surgical options, radiation therapy, hormone therapy, chemotherapy, and biologic therapies. This episode will provide guidance on interpreting pathology reports for breast lesions, delivering a breast cancer diagnosis, and supporting patients undergoing breast cancer treatments including managing symptoms of anti-estrogen therapies. Lastly, we will cover cancer survivorship care, and review how to monitor for recurrence in our breast cancer survivors in the primary care setting. View CE information and claim credit: https://stanford.cloud-cme.com/course... Key moments: 00:00:00 Introduction to Women’s Health Vodcast series 00:02:00 Current understanding of the natural history of DCIS 00:04:00 Removal of DCIS and its impact on the development of invasive cancer risk 00:07:05 COMET Trial preliminary data 00:09:00 Radiation treatment 00:12:30 Screening after treating DCIS 00:13:45 Atypical Ductal Hyperplasia management 00:16:30 When to consider further imaging or referral for patients who have normal imaging 00:20:00 Important aspects of pathology reports 00:26:50 Verbiage to explain pathology reports to patients 00:29:10 Staging pathway for invasive breast cancer 00:35:50 Lymph nodes on diagnostic mammogram or ultrasound 00:37:15 Lymph node biopsies and invasive breast cancer 00:40:45 How to answer patients question of needing chemotherapy 00:42:10 PARP Inhibitors and other progress in precision medicine 00:45:55 Short and long term impacts of breast cancer treatments 00:50:10 Topical vaginal estrogens 00:52:10 Non-Hormonal agents and vasomotor symptoms 00:55:20 Recommendations for arthralgia 00:57:20 Psychological impacts and primary care support 01:03:00 Monitoring for recurrence 01:08:10 Key takeaways